Showing results (161-170 of 369) with videos related to
Sort By:
Pageof 37
The Journal of Clinical Psychiatry|May 25, 2010
Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trialDavid E Kemp, Joseph R Calabrese, Quynh-Van Tran, et al.Bipolar Disorders|October 20, 2019
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 studyWillie R Earley, Maria V Burgess, Barbara Khan, et al.Neuropsychologia|January 17, 2004
Hemodynamic differences in the activation of the prefrontal cortex: attention vs. higher cognitive processingMotomi Toichi, Robert L Findling, Yasutaka Kubota, et al.Journal of Clinical Psychopharmacology|November 18, 2006
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)Michael E Thase, Wayne Macfadden, Richard H Weisler, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 25, 2007
The relationship of personality traits to substance abuse in patients with bipolar disorderGonzalo Haro, Joseph R Calabrese, Christina Larsson, et al.Traffic Injury Prevention|September 28, 2014
The prevalence and correlates of risky driving behavior among National Guard soldiersKatherine J Hoggatt, Marta R Prescott, Emily Goldmann, et al.The Journal of Clinical Psychiatry|May 3, 2008
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studiesRichard H Weisler, Joseph R Calabrese, Michael E Thase, et al.Journal of Affective Disorders|December 25, 2018
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorderRoger S McIntyre, Joseph R Calabrese, Andrew A Nierenberg, et al.Journal of Affective Disorders|July 30, 2017
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorderOle Köhler-Forsberg, Trine Madsen, Ida Behrendt-Møller, et al.The Journal of Clinical Psychiatry|January 7, 2015
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled studyJoseph R Calabrese, Paul E Keck, Anju Starace, et al.Pageof 37